AIMS: Alcohol effects or drug-alcohol interactions are preferably studied at constant blood levels. To achieve pseudo-steady state levels, various methods are used, which usually produce adequate averages but variable individual concentration profiles. The aim was to compare two modes of alcohol administration: a 'two-step prekinetic procedure' and a 'clamping method'. METHODS: The two-step prekinetic procedure started with determination of individual pharmacokinetic (PK) parameters, during a prestudy occasion. Individual infusion regimens were calculated afterwards, based on a pseudo-steady state breath alcohol concentration (BrAC) of 0.65 g l(-1) and applied on a separate occasion. For the clamping procedure, a spreadsheet-based paradigm was developed using BrAC-guided adjustments of infusion rates, to maintain stable BrAC levels of 0.6 g l(-1). RESULTS: The mean BrAC during clamping [0.61 g l(-1), 95% confidence interval (CI) 0.58, 0.63] did not differ from its intended level of 0.6 g l(-1) (1.0% on average). In contrast, the mean BrAC during the prekinetic procedure was significantly lower than the 0.65 g l(-1) set-point (0.59 g l(-1), 95% CI 0.54, 0.63) and deviated from this target by 9.7% on average. The clamping method also showed less variation between subjects [coefficient of variation (CV) 6.2%] compared with the prekinetic procedure (CV 14.6%). CONCLUSIONS: Although the two methods differ considerably in their approach, clamping of BrAC resulted in more accurate alcohol levels than infusion based on PK modelling and does not require an extra prestudy occasion. The novel alcohol clamping paradigm can be of value in future studies of alcohol interactions or the pharmacodynamics of acute alcohol administration.
RCT Entities:
AIMS: Alcohol effects or drug-alcohol interactions are preferably studied at constant blood levels. To achieve pseudo-steady state levels, various methods are used, which usually produce adequate averages but variable individual concentration profiles. The aim was to compare two modes of alcohol administration: a 'two-step prekinetic procedure' and a 'clamping method'. METHODS: The two-step prekinetic procedure started with determination of individual pharmacokinetic (PK) parameters, during a prestudy occasion. Individual infusion regimens were calculated afterwards, based on a pseudo-steady state breath alcohol concentration (BrAC) of 0.65 g l(-1) and applied on a separate occasion. For the clamping procedure, a spreadsheet-based paradigm was developed using BrAC-guided adjustments of infusion rates, to maintain stable BrAC levels of 0.6 g l(-1). RESULTS: The mean BrAC during clamping [0.61 g l(-1), 95% confidence interval (CI) 0.58, 0.63] did not differ from its intended level of 0.6 g l(-1) (1.0% on average). In contrast, the mean BrAC during the prekinetic procedure was significantly lower than the 0.65 g l(-1) set-point (0.59 g l(-1), 95% CI 0.54, 0.63) and deviated from this target by 9.7% on average. The clamping method also showed less variation between subjects [coefficient of variation (CV) 6.2%] compared with the prekinetic procedure (CV 14.6%). CONCLUSIONS: Although the two methods differ considerably in their approach, clamping of BrAC resulted in more accurate alcohol levels than infusion based on PK modelling and does not require an extra prestudy occasion. The novel alcohol clamping paradigm can be of value in future studies of alcohol interactions or the pharmacodynamics of acute alcohol administration.
Authors: A L van Steveninck; R Gieschke; H C Schoemaker; M S Pieters; J M Kroon; D D Breimer; A F Cohen Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530
Authors: M Soyka; M Albus; N Kathmann; A Finelli; S Hofstetter; R Holzbach; B Immler; P Sand Journal: Eur Arch Psychiatry Clin Neurosci Date: 1993 Impact factor: 5.270
Authors: Remco W M Zoethout; Rik C Schoemaker; Lineke Zuurman; Hans van Pelt; Albert Dahan; Adam F Cohen; Joop M A van Gerven Journal: Br J Clin Pharmacol Date: 2009-10 Impact factor: 4.335
Authors: Najmeh Khalili-Mahani; Remco M W Zoethout; Christian F Beckmann; Evelinda Baerends; Marieke L de Kam; Roelof P Soeter; Albert Dahan; Mark A van Buchem; Joop M A van Gerven; Serge A R B Rombouts Journal: Hum Brain Mapp Date: 2011-03-09 Impact factor: 5.038
Authors: Najmeh Khalili-Mahani; Matthias J van Osch; Mark de Rooij; Christian F Beckmann; Mark A van Buchem; Albert Dahan; Johannes M van Gerven; Serge A R B Rombouts Journal: Hum Brain Mapp Date: 2012-12-26 Impact factor: 5.038
Authors: Erik T te Beek; Justin L Hay; Jonathan N Bullman; Clare Burgess; Kimberly J Nahon; Erica S Klaassen; Frank A Gray; Joop M A van Gerven Journal: Br J Clin Pharmacol Date: 2013-05 Impact factor: 4.335
Authors: Marieke M Lansbergen; Glenn J H Dumont; Joop M A van Gerven; Jan K Buitelaar; Robbert-Jan Verkes Journal: Psychopharmacology (Berl) Date: 2010-10-06 Impact factor: 4.530
Authors: Najmeh Khalili-Mahani; Matthias J P van Osch; Evelinda Baerends; Roelof P Soeter; Marieke de Kam; Remco W M Zoethout; Albert Dahan; Mark A van Buchem; Joop M A van Gerven; Serge A R B Rombouts Journal: J Cereb Blood Flow Metab Date: 2011-01-19 Impact factor: 6.200